BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33858692)

  • 21. Drug reaction with eosinophilia and systemic symptoms in a cohort of Asian children.
    Han XD; Koh MJ; Wong SMY
    Pediatr Dermatol; 2019 May; 36(3):324-329. PubMed ID: 30920020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug reaction with eosinophilia and systemic symptoms (DRESS): A histopathology based analysis.
    Sasidharanpillai S; Govindan A; Riyaz N; Binitha MP; Muhammed K; Khader A; Reena Mariyath OK; Simin M; Subin K
    Indian J Dermatol Venereol Leprol; 2016; 82(1):28-36. PubMed ID: 26728807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of DRESS Syndrome in the Elderly: A Comparative Study of 55 Patients.
    Bahloul E; Trimeche K; Sellami K; Hammami F; Hayder F; Chaabouni R; Amouri M; Masmoudi A; Mseddi M; Boudeya S; Turki H
    Dermatitis; 2024; 35(1):55-60. PubMed ID: 37669109
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug reaction with eosinophilia and systemic symptoms (DRESS) in the pediatric population: A systematic review of the literature.
    Kim GY; Anderson KR; Davis DMR; Hand JL; Tollefson MM
    J Am Acad Dermatol; 2020 Nov; 83(5):1323-1330. PubMed ID: 32247873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug reaction with eosinophilia and systemic symptoms: observations from a tertiary care institution.
    Sasidharanpillai S; Riyaz N; Rajan U; Binitha MP; Khader A; Mariyath OK; John R; Puravoor J
    Indian J Dermatol Venereol Leprol; 2014; 80(3):221-8. PubMed ID: 24823399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of DRESS syndrome.
    López-Rocha E; Blancas L; Rodríguez-Mireles K; Gaspar-López A; O'Farrill-Romanillos P; Amaya-Mejía A; Galindo-Pacheco L; Campos-Romero F; Aguilar-Hinojosa N; Suárez G
    Rev Alerg Mex; 2014; 61(1):14-23. PubMed ID: 24912998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukemoid reaction in minocycline-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: A brief report.
    Shea M; Weese K; Dhossche J
    Pediatr Dermatol; 2024; 41(1):141-142. PubMed ID: 37496096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug reactions with eosinophilia and systemic symptoms induced by immune checkpoint inhibitors: an international cohort of 13 cases.
    Ingen-Housz-Oro S; Milpied B; Bensaid B; Elshot Y; Brüggen MC; Starace M; Kaffenberger BH; Carrera C; Pham-Ledard A; Freites-Martinez A; Sanchez-Pena P; Lebrun-Vignes B; French LE; Sibaud V
    Melanoma Res; 2023 Apr; 33(2):155-158. PubMed ID: 36749114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DRESS syndrome: a detailed insight.
    Behera SK; Das S; Xavier AS; Selvarajan S
    Hosp Pract (1995); 2018 Aug; 46(3):152-162. PubMed ID: 29519170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discriminating minor and major forms of drug reaction with eosinophilia and systemic symptoms: Facial edema aligns to the severe phenotype.
    Momen SE; Diaz-Cano S; Walsh S; Creamer D
    J Am Acad Dermatol; 2021 Sep; 85(3):645-652. PubMed ID: 33872719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathologic spectrum of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): a diagnosis that needs clinico-pathological correlation.
    Borroni G; Torti S; Pezzini C; Vassallo C; Rosso R; D'Ospina RM; Tomasini C; Brazzelli V
    G Ital Dermatol Venereol; 2014 Jun; 149(3):291-300. PubMed ID: 24819756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to recognize and manage challenging DRESS cases: Two case reports and a review of the literature.
    Ak T; Erdem S; Durmus RB; Kimyon U; Engin B; Bavunoglu I
    Dermatol Ther; 2022 Nov; 35(11):e15785. PubMed ID: 35997939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Young Child with Eosinophilia, Rash, and Multisystem Illness: Drug Rash, Eosinophilia, and Systemic Symptoms Syndrome After Receipt of Fluoxetine.
    Vignesh P; Kishore J; Kumar A; Vinay K; Dogra S; Sreedharanunni S; Prasun Giri P; Pal P; Ghosh A
    Pediatr Dermatol; 2017 May; 34(3):e120-e125. PubMed ID: 28523892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unravelling cases of clozapine-related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in patients reported otherwise: A systematic review.
    de Filippis R; Soldevila-Matías P; Guinart D; De Fazio P; Rubio JM; Kane JM; Schoretsanitis G
    J Psychopharmacol; 2021 Sep; 35(9):1062-1073. PubMed ID: 34044659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug reaction with eosinophilia and systemic symptoms syndrome is not uncommon and shows better clinical outcome than generally recognised.
    Nam YH; Park MR; Nam HJ; Lee SK; Kim KH; Roh MS; Um SJ; Son CH
    Allergol Immunopathol (Madr); 2015; 43(1):19-24. PubMed ID: 24388810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug reaction with eosinophilia and systemic symptoms may occur within 2 weeks of drug exposure: A retrospective study.
    Soria A; Bernier C; Veyrac G; Barbaud A; Puymirat E; Milpied B
    J Am Acad Dermatol; 2020 Mar; 82(3):606-611. PubMed ID: 31562941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Permanent renal sequelae secondary to drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by quetiapine.
    Torroba Sanz B; Mendez Martínez E; Cacho Asenjo E; Aquerreta Gonzalez I
    Eur J Hosp Pharm; 2021 Sep; 28(5):285-288. PubMed ID: 34426483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [DRESS syndrome: Report of nine cases].
    Ocampo-Garza J; Ocampo-Garza SS; Martínez-Villarreal JD; Barbosa-Moreno LE; Guerrero-González GA; Ocampo-Candiani J
    Rev Med Chil; 2015 May; 143(5):577-83. PubMed ID: 26203568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of Adult Patients With Drug Reaction With Eosinophilia and Systemic Symptoms: A Delphi-Based International Consensus.
    Brüggen MC; Walsh S; Ameri MM; Anasiewicz N; Maverakis E; French LE; Ingen-Housz-Oro S; ; Abe R; Ardern-Jones M; Assier H; Barbaud A; Bensaid B; Bernal W; Bernier C; Brassard A; Brezinová E; Cabañas R; Cardones A; Chu CY; Chua SL; Descamps V; Didona B; Divito SJ; Dodiuk-Gad R; Elman S; Gaspar K; Mortz CG; Hama N; Lee HY; Horváth B; Jörg L; Kaffenberger BH; Kucinskiene V; Lebrun-Vignes B; Lehloenya RJ; Meyersburg D; Micheletti R; Milpied B; Miyagawa F; Mostaghimi A; Nägeli M; Naldi L; Oppel E; Phillips EJ; Pirani T; Ranki A; Mälkönen T; Rosenbach M; Salavastru C; Staumont-Salle D; Sandberg H; Setterfield J; Shinkai K; Shiohara T; Soria A; Tartar D; Tiplica GS; Traidl S; Vorobyev A; von Wachter C; Worswick S; Cho YT
    JAMA Dermatol; 2024 Jan; 160(1):37-44. PubMed ID: 37966824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug reaction with eosinophilia and systemic symptoms (DRESS) and its relation with autoimmunity in a reference center in Mexico.
    Matta JM; Flores SM; Cherit JD
    An Bras Dermatol; 2017; 92(1):30-33. PubMed ID: 28225953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.